Sandhoffova nemoc [Sandhoff Disease]

tematický
1
Termíny

GM2 gangliosidóza II
GM2 gangliosidóza, typ II
Sandhoffova nemoc u dospělých
Sandhoffova nemoc, dospělá forma
Sandhoffova nemoc, dospělý typ
Sandhoffova nemoc, infantilní forma
Sandhoffova nemoc, infantilní typ
Sandhoffova nemoc, juvenilní forma
Sandhoffova nemoc, juvenilní typ
úplný deficit hexosaminidázy
úplný nedostatek hexosaminidázy

 

Adult Sandhoff Disease
beta-Hexosaminidase-beta-Subunit Deficiency
Deficiency Disease, Hexosaminidase A and B
G(M2) Gangliosidosis, Type II
Gangliosidosis G(M2), Type II
Gangliosidosis GM2, Type II
GM2 Gangliosidosis, Type 2
GM2 Gangliosidosis, Type II
GM2-Gangliosidosis, Type II
Hexosaminidase A and B Deficiency Disease
Hexosaminidases A And B Deficiency
Infantile Sandhoff Disease
Juvenile Sandhoff Disease
Sandhoff Disease, Adult
Sandhoff Disease, Adult Type
Sandhoff Disease, Infantile
Sandhoff Disease, Infantile Type
Sandhoff Disease, Juvenile
Sandhoff Disease, Juvenile Type
Sandhoff-Jatzkewitz-Pilz Disease
Sandhoff's Disease
Total Hexosaminidase Deficiency

Perzistentní odkaz   https://www.medvik.cz/link/D012497
Definice

Hereditární onemocnění postihující metabolismus lipidů, spočívající v deficitu obou izoenzymů b-hexosaminidázy (A i B). Dědičnost je autozomálně recesivní (lokus 5q11). Infantilní typ imituje Tayovu-Sachsovu nemoc, s tím, že zde je vždy přítomna hepatosplenomegalie. Juvenilní typ se manifestuje v první dekádě života ataxií, dysartrií a mentálním zaostáváním. Prognóza obou forem je infaustní. (cit. Velký lékařský slovník online, 2018 http://lekarske.slovniky.cz)

An autosomal recessive neurodegenerative disorder characterized by an accumulation of G(M2) GANGLIOSIDE in neurons and other tissues. It is caused by mutation in the common beta subunit of HEXOSAMINIDASE A and HEXOSAMINIDASE B. Thus this disease is also known as the O variant since both hexosaminidase A and B are missing. Clinically, it is indistinguishable from TAY-SACHS DISEASE.

DUI
D012497 MeSH Prohlížeč
CUI
M0019413
Předchozí užití
Lipoidosis (1966-1978); Gangliosides (1966-1978); Gangliosidosis (1976-1978); G(M2) Ganglioside (1975-1978); Hexosaminidases (1971-1978); Sphingolipidosis (1974-1978)
Historická pozn.
1979
Veřejná pozn.
1979

C Nemoci
C10.228.140 nemoci mozku 1 178
C10.228.140.163 metabolické nemoci mozku 84
C10.228.140.163.100.435.825 sfingolipidózy 12
C10.228.140.163.100.435.825.300 gangliosidóza 11
C10.228.140.163.100.435.825.300.300 gangliosidózy GM2 2
C10.228.140.163.100.435.825.300.300.249 Sandhoffova nemoc 1
C10.228.140.163.100.435.825.300.300.500 Tay-Sachsova nemoc 15
C10.228.140.163.100.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C16.320.565.189.435.825 sfingolipidózy 12
C16.320.565.189.435.825.300 gangliosidóza 11
C16.320.565.189.435.825.300.300 gangliosidózy GM2 2
C16.320.565.189.435.825.300.300.249 Sandhoffova nemoc 1
C16.320.565.189.435.825.300.300.500 Tay-Sachsova nemoc 15
C16.320.565.189.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C16.320.565.398.641 lipidózy 35
C16.320.565.398.641.803 sfingolipidózy 12
C16.320.565.398.641.803.350 gangliosidóza 11
C16.320.565.398.641.803.350.300 gangliosidózy GM2 2
C16.320.565.398.641.803.350.300.700 Sandhoffova nemoc 1
C16.320.565.398.641.803.350.300.850 Tay-Sachsova nemoc 15
C16.320.565.398.641.803.350.300.925 Tay-Sachsova nemoc, varianta AB
C16.320.565.595.554.825 sfingolipidózy 12
C16.320.565.595.554.825.300 gangliosidóza 11
C16.320.565.595.554.825.300.300 gangliosidózy GM2 2
C16.320.565.595.554.825.300.300.800 Sandhoffova nemoc 1
C16.320.565.595.554.825.300.300.840 Tay-Sachsova nemoc 15
C16.320.565.595.554.825.300.300.920 Tay-Sachsova nemoc, varianta AB
C18.452 metabolické nemoci 1 196
C18.452.132.100.435.825 sfingolipidózy 12
C18.452.132.100.435.825.300 gangliosidóza 11
C18.452.132.100.435.825.300.300 gangliosidózy GM2 2
C18.452.132.100.435.825.300.300.249 Sandhoffova nemoc 1
C18.452.132.100.435.825.300.300.500 Tay-Sachsova nemoc 15
C18.452.132.100.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C18.452.584.563.641 lipidózy 35
C18.452.584.563.641.803 sfingolipidózy 12
C18.452.584.563.641.803.350 gangliosidóza 11
C18.452.584.563.641.803.350.300 gangliosidózy GM2 2
C18.452.584.563.641.803.350.300.700 Sandhoffova nemoc 1
C18.452.584.563.641.803.350.300.850 Tay-Sachsova nemoc 15
C18.452.584.563.641.803.350.300.925 Tay-Sachsova nemoc, varianta AB
C18.452.648.189.435.825 sfingolipidózy 12
C18.452.648.189.435.825.300 gangliosidóza 11
C18.452.648.189.435.825.300.300 gangliosidózy GM2 2
C18.452.648.189.435.825.300.300.249 Sandhoffova nemoc 1
C18.452.648.189.435.825.300.300.500 Tay-Sachsova nemoc 15
C18.452.648.189.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C18.452.648.398.641 lipidózy 35
C18.452.648.398.641.803 sfingolipidózy 12
C18.452.648.398.641.803.350 gangliosidóza 11
C18.452.648.398.641.803.350.300 gangliosidózy GM2 2
C18.452.648.398.641.803.350.300.700 Sandhoffova nemoc 1
C18.452.648.398.641.803.350.300.850 Tay-Sachsova nemoc 15
C18.452.648.398.641.803.350.300.925 Tay-Sachsova nemoc, varianta AB
C18.452.648.595.554.825 sfingolipidózy 12
C18.452.648.595.554.825.300 gangliosidóza 11
C18.452.648.595.554.825.300.300 gangliosidózy GM2 2
C18.452.648.595.554.825.300.300.800 Sandhoffova nemoc 1
C18.452.648.595.554.825.300.300.840 Tay-Sachsova nemoc 15
C18.452.648.595.554.825.300.300.920 Tay-Sachsova nemoc, varianta AB